Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director
Cannabis Law Report
JANUARY 4, 2022
NYSE: AMAM), a position he previously held from 2010 through 2015. I am so very proud of all Anebulo has achieved over the past 18 months, including building out a highly effective team, securing new intellectual property protection, preparing and starting a proof-of-concept clinical trial, advancing regulatory discussions with the U.S.
Let's personalize your content